Express News | Ocugen Announced That The Data And Safety Monitoring Board For OCU410 ArMaDa Clinical Trial Recently Convened And Approved The Continuation Of The Second Phase Of The Phase 1/2 Study

BenzingaDec 19 06:43 ET

Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

GlobeNewswireDec 19 06:38 ET

Malaysia Closing Bell on Dec 17 | TENAGA Was the Top Gainer of FBM KLCI

Moomoo NewsDec 17 04:20 ET

Malaysian Shares Edge Down 0.2%; May Trade Sideways -- Market Talk

WSJDec 16 20:08 ET

Special Permit Required For Diesel Purchases Exceeding Limit – Kpdn

BernamaDec 12 20:47 ET

Malaysia Closing Bell on Dec 11 | NESTLE Was the Top Gainer of FBM KLCI

Moomoo NewsDec 11 04:20 ET